Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Association between BMI, Weight Change and Risk of Lung Cancer in the PLCO Cancer Screening Trial Yixiang Zhang The Second Affiliated Hospital of Fujian Medical University PLCO Apr 10, 2023 PLCO-1194
Development of a Machine Learning Model for Risk Prediction of Ovarian Cancer Yixiang Zhang The Second Affiliated Hospital of Fujian Medical University PLCO Apr 10, 2023 PLCO-1192
Development of a pathological image analysis and cell classification pipeline with convolutional neural network Honglei Zhang Yunnan University of Traditional Chinese Medicine NLST Mar 30, 2023 NLST-1036
Imbalanced Learning on Cancer Datasets Weitong Huang Australian National University PLCO Mar 29, 2023 PLCO-1189
The delays in ovarian cancer treatment and their effect on OS Kaja Michalczyk Pomeranian Medical University PLCO Mar 29, 2023 PLCO-1187
AI-based tools to support decision-making in lung cancer screening Johanna Topalis Department of Radiology, University Hospital, LMU Munich NLST Mar 28, 2023 NLST-1034
Causal Counterfactual visualisation for human causal decision making – A case study in healthcare xujiong ye University of Lincoln NLST Mar 28, 2023 NLST-1033
The Relationship between lung cancer and regular screenings Abbie Anderson Des Moines Area Community College NLST Mar 28, 2023 NLST-1031
Multimodal self-supervised medical image segmentation xin lin Hangzhou Dianzi University NLST Mar 21, 2023 NLST-1029
A Research Investigation on the Association between Various Dietary Patterns and the Incidence Risk of Pancreatic Cancer Xi Zhang Beijing Chao-Yang Hospital, Capital Medical University PLCO Mar 21, 2023 PLCO-1182
Imaging Biomarkers and Lung Cancer Development and Mortality DAVID WILSON University of pittsburgh NLST Mar 21, 2023 NLST-1025
Quantifying cancer screening overdiagnosis using synthetic excess incidence Stuart Baker National Cancer Institute NLST Mar 20, 2023 NLST-1026
Ultra-processed food consumption and cancer-related mortality in patients with colorectal, lung, prostate, or breast cancer: a post hoc analysis of the PLCO cancer screening trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Mar 20, 2023 PLCO-1180
Quantifying cancer screening overdiagnosis using synthetic excess incidence Stuart Baker National Cancer Institute PLCO Mar 20, 2023 PLCO-1178
Association between adherence to the Eat-Lancet Diet and lung cancer incidence and mortality in the US population: A prospective cohort study Linglong Peng The Second Affiliated Hospital of Chongqing Medical University PLCO Mar 16, 2023 PLCO-1177
Genome-Wide Association Study of Circulating Estradiol in Postmenopausal Women Neil Murphy International Agency for Research on Cancer PLCO Mar 8, 2023 PLCO-1170
Pan-cancer genome-wide association study of tissue disruption phenotypes on standard histologic images from PLCO Mustapha Abubakar Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA PLCO Mar 8, 2023 PLCOI-1172
Gender Differences in Lung Cancer Screening in NLST Data: A Comparative Analysis Mohamed Rahouma Weill Cornell Medicine/ New York Presbyterian Hospital NLST Mar 8, 2023 NLST-1023
Oncology department in India w.r.t the rest of the world Saurabh Saurabh Madras School of Economics, Chennai NLST Mar 8, 2023 NLST-1022
A Graph-transformer for Lung Subtype Classification on Whole Slide Images Yuxin Kang Northwest University NLST Mar 8, 2023 NLST-1021